Publication | Open Access

Empagliflozin reduces high glucose-induced oxidative stress and miR-21-dependent TRAF3IP2 induction and RECK suppression, and inhibits human renal proximal tubular epithelial cell migration and epithelial-to-mesenchymal transition

Epithelial-to-mesenchymal TransitionMedicineImmunologyReck SuppressionMir-21-dependent Traf3ip2 InductionDiabetic Kidney DiseaseMicrorna DetectionKidney Tubule RemodelingChronic Kidney DiseaseCell BiologyCell SignalingTumor MicroenvironmentKidney ResearchOxidative Stress